Segmental liver resection for colorectal metastases

Area of Science:

• Hepatobiliary surgery
• Surgical oncology
• Gastroenterology

Background:

• Debate exists regarding segmental versus major liver resection for resectable liver metastases when both are feasible.
• Colorectal cancer liver metastases (CRLM) are a common clinical challenge requiring effective surgical management.

Purpose of the Study:

• To compare outcomes of segmental versus major liver resection for CRLM.
• To evaluate perioperative morbidity, mortality, and long-term survival rates between the two surgical approaches.

Main Methods:

• Retrospective review of 188 liver resections for CRLM (2000-2007).
• Comparison of segmental resection (n=76) versus major resection (n=112).
• Analysis of morbidity, mortality, blood loss, transfusion requirements, disease-free survival (DFS), and overall survival (OS).

Main Results:

• Segmental resection had zero mortality versus 3.7% in major resection (p<0.05).
• Lower complication rates (23% vs 33%), less blood loss (423 mL vs 1245 mL), and reduced transfusion needs (0.5 vs 2 units) in segmental resection (p<0.001).
• No significant difference in DFS (p=0.545) or OS (p=0.750) between groups.

Conclusions:

• Segmental liver resection is a viable option for CRLM, achieving comparable survival to major resection.
• Segmental resection demonstrates superior perioperative safety with reduced morbidity and mortality.
• This approach allows for liver volume conservation while maintaining oncological efficacy.